Solpadeine is the brand name of a range of analgesic medication containing various amounts of paracetamol, ibuprofen, caffeine and codeine, currently made by Omega Pharma. The range was previously made by GlaxoSmithKline, which sold its portfolio of over-the-counter drugs to Omega Pharma in 2012.
In the United Kingdom there are four different medicines using the Solpadeine name, with no common active ingredient between them. The range includes:
- Solpadeine Headache, containing paracetamol with caffeine
- Solpadeine Plus, a compound analgesic containing paracetamol and codeine (co-codamol), with caffeine
- Solpadeine Max, a compound analgesic containing paracetamol and codeine (with a higher codeine content than Solpadeine Plus), but without the caffeine
- Solpadeine Migraine, a compound analgesic containing ibuprofen and codeine
In 2016 it was one of the biggest selling branded over-the-counter medications sold in Great Britain, with sales of £43.1 million.
- "Omega Pharma - Solpadeine". Omega-pharma.pl. Retrieved 2013-09-14.
- Corporate Comms (2012-03-15). "GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands". Us.gsk.com. Retrieved 2013-09-14.
- "A breakdown of the over-the-counter medicines market in Britain in 2016". Pharmaceutical Journal. 28 April 2017. Retrieved 29 May 2017.
- "Panadeine - GlaxoSmithKline New Zealand". Gsk.co.nz. 2008-11-17. Retrieved 2013-09-14.
|This analgesic-related article is a stub. You can help Wikipedia by expanding it.|